Graeme J. Moyle
Corporate Officer/Principal en Chelsea & Westminster Hospital .
Perfil
Graeme J.
Moyle is currently the Director-HIV Research Strategy at Chelsea & Westminster Hospital since 1994.
He previously worked as an Independent Director at Tobira Therapeutics, Inc. Dr. Moyle holds a doctorate degree from the University of Adelaide.
Cargos activos de Graeme J. Moyle
Empresas | Cargo | Inicio |
---|---|---|
Chelsea & Westminster Hospital | Corporate Officer/Principal | 01/01/1994 |
Antiguos cargos conocidos de Graeme J. Moyle.
Empresas | Cargo | Fin |
---|---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Director/Miembro de la Junta | - |
Formación de Graeme J. Moyle.
University of Adelaide | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Chelsea & Westminster Hospital |
- Bolsa de valores
- Insiders
- Graeme J. Moyle